Olfactory deficits and cardiac 123 I-MIBG in Parkinson's disease related to the LRRK2 R1441G and G2019S mutations-Reference-Cited by-同舟云学术

Olfactory deficits and cardiac 123 I-MIBG in Parkinson's disease related to the LRRK2 R1441G and G2019S mutations

Published:2011-05-24 Issue:11 Volume:26 Page:2026-2031
ISSN:0885-3185
Container-title:Movement Disorders
language:en
Short-container-title:Mov. Disord.

Author:

Ruiz-Martínez Javier,Gorostidi Ana,Goyenechea Estibaliz,Alzualde Ainhoa,Poza Juan José,Rodríguez Francisco,Bergareche Alberto,Moreno Fermín,López de Munain Adolfo,Martí Massó José F.

Publisher

Wiley

Subject

Neurology (clinical),Neurology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/mds.23773/fullpdf

Reference38 articles.

1. The scientific and clinical basis for the treatment of Parkinson disease;Olanow;Neurology,2009

2. Lewy body-type degeneration in cardiac plexus in Parkinson's and incidental Lewy body diseases;Iwanaga;Neurology,1999

3. Staging of brain pathology related to sporadic Parkinson's disease;Braak;Neurobiol Aging,2003

4. Bilateral olfactory dysfunction in early stage treated and untreated idiopathic Parkinson's disease;Doty;J Neurol Neurosurg Psychiatry,1992

5. FP-CIT and MIBG scintigraphy in early Parkinson's disease;Spiegel;Mov Disord,2005

Cited by 51 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Towards a Global View of Parkinson's Disease Genetics;Annals of Neurology;2024-04

2. Cardiac 123I-Metaiodobenzylguanidine (MIBG) Scintigraphy in Parkinson’s Disease: A Comprehensive Review;Brain Sciences;2023-10-18

3. Olfactory dysfunction and its related molecular mechanisms in Parkinson’s disease;Neural Regeneration Research;2023-07-20

4. Overview of the Impact of Pathogenic LRRK2 Mutations in Parkinson’s Disease;Biomolecules;2023-05-16

5. LRRK2 and Parkinson's disease: from genetics to targeted therapy;Annals of Clinical and Translational Neurology;2023-04-06